Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Mariano Arosemena

Vascular Surgery Bradenton, FL Medical Doctor

NPI 1407051121 CMS profile 1384009

6220 Manatee Ave W Ste 203, Bradenton, FL 34209

Open in the dashboard

General payments

$471,528

676 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Mariano Arosemena of Bradenton, FL is reported in the CMS Open Payments database as having received $471,528 across 676 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $72,203 101
2024 General $128,085 158
2023 General $137,615 167
2022 General $87,387 147
2021 General $28,925 35
2020 General $11,835 29
2019 General $5,477 39

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mariano Arosemena
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Mariano Arosemena were reported at $72,203. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Mariano Arosemena Vascular Surgery median Middle half National median
2019 $5,477 $796 $226–$2,363 $163
2020 $11,835 $348 $118–$1,110 $114
2021 $28,925 $471 $158–$1,421 $132
2022 $87,387 $725 $222–$2,183 $149
2023 $137,615 $836 $257–$2,440 $160
2024 $128,085 $909 $252–$2,619 $164
2025 $72,203 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Silk Road Medical, Inc. $385,848 428 payments
  2. Boston Scientific Corporation $70,232 64 payments
  3. Cook Medical LLC $3,971 65 payments
  4. W. L. Gore & Associates, Inc. $2,340 26 payments
  5. Penumbra, Inc. $2,243 18 payments
  6. Cook Incorporated $1,781 3 payments
  7. Medtronic Vascular, Inc. $1,407 15 payments
  8. Centinel Spine, LLC $1,267 6 payments
  9. Medtronic, Inc. $435 9 payments
  10. Shockwave Medical, Inc $355 7 payments
  11. Other $1,648 35 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $251,697 62 payments
  2. Compensation for serving as faculty or as a speaker for a medical education program $76,500 11 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $58,500 15 payments
  4. Travel and Lodging $55,941 220 payments
  5. Food and Beverage $28,890 368 payments
Products named General payments · program years 2019–2025
  1. ENROUTE Transcarotid Stent $370,833 396 payments
  2. ENROUTE Transcarotid Neuroprotection System Cardiology/Vascular Diseases $370,833 396 payments
  3. ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter $126,693 132 payments
  4. ENROUTE Transcarotid Neuroprotection System Cardiology/Vascular Diseases $126,693 132 payments
  5. ENROUTE Transcarotid Neuroprotection System Cardiology Vascular Diseases $38,004 24 payments
  6. ENHANCE Transcarotid Peripheral Access Kit $28,321 24 payments
  7. ENROUTE .014 Guidewire $28,321 24 payments
  8. ENROUTE Transcarotid Neuroprotection System Enroute Nps Angle US - Pi $23,314 16 payments
  9. ENROUTE 0.014 Guidewire $15,015 32 payments
  10. ENROUTE Transcarotid Stent System $15,015 32 payments
  11. Other $55,091 289 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 63 billing codes

Paid by Medicare

$132,477

Medicare's payments for the services billed

Medicare patients

401

Average age 75

Services billed

852

190 women, 211 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 61%
Arthritis 58%
Diabetes 50%
Chronic kidney disease 44%
Heart failure 37%
COPD 37%
Atrial fibrillation 34%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

676 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record